Show Search Form
human indexable | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||
registered interest | |||||||||||||||||
answer date | |||||||||||||||||
date | |||||||||||||||||
date tabled | |||||||||||||||||
ddp created | |||||||||||||||||
ddp modified | |||||||||||||||||
answering body |
|
||||||||||||||||
question status | Tabled | ||||||||||||||||
answering dept id | 17 | ||||||||||||||||
answering dept short name | Health | ||||||||||||||||
answering dept sort name | Health | ||||||||||||||||
hansard heading | Kidney Cancer: Scotland | ||||||||||||||||
house id | 1 | ||||||||||||||||
identifier | 218530 | ||||||||||||||||
legislature |
|
||||||||||||||||
parliament number | 55 | ||||||||||||||||
question first answered |
|
||||||||||||||||
question text | To ask the Secretary of State for Health, with reference to the approval by the Scottish Medicines Consortium of two second line treatments for renal cell carcinoma, if he will direct the Cancer Drug Fund panel to ensure that patients in England will continue to have access to treatments that are available on the NHS in Scotland for that condition. | ||||||||||||||||
session |
|
||||||||||||||||
session number | 4 | ||||||||||||||||
tabling member constituency | West Lancashire | ||||||||||||||||
tabling member printed |
|
||||||||||||||||
title | House of Commons Tabled Parliamentary Question 2014/15 218530 | ||||||||||||||||
type |
|
||||||||||||||||
uin | 218530 | ||||||||||||||||
version | 1 | ||||||||||||||||
written parliamentary question type | NamedDay | ||||||||||||||||
answer |
|
||||||||||||||||
creator |
|
||||||||||||||||
publisher | 25259 | ||||||||||||||||
tabling member |
|